DE69636720D1 - Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung - Google Patents
Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendungInfo
- Publication number
- DE69636720D1 DE69636720D1 DE69636720T DE69636720T DE69636720D1 DE 69636720 D1 DE69636720 D1 DE 69636720D1 DE 69636720 T DE69636720 T DE 69636720T DE 69636720 T DE69636720 T DE 69636720T DE 69636720 D1 DE69636720 D1 DE 69636720D1
- Authority
- DE
- Germany
- Prior art keywords
- fhf
- factor
- fibroblasted
- methods
- growth factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003102 growth factor Substances 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 108050003239 Fibroblast growth factor 12 Proteins 0.000 abstract 1
- 102100028417 Fibroblast growth factor 12 Human genes 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US439725 | 1995-05-12 | ||
US08/439,725 US5693775A (en) | 1995-05-12 | 1995-05-12 | Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use |
PCT/US1996/006664 WO1996035708A1 (en) | 1995-05-12 | 1996-05-10 | Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69636720D1 true DE69636720D1 (de) | 2007-01-04 |
DE69636720T2 DE69636720T2 (de) | 2007-10-18 |
Family
ID=23745874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69636720T Expired - Fee Related DE69636720T2 (de) | 1995-05-12 | 1996-05-10 | Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung |
Country Status (8)
Country | Link |
---|---|
US (4) | US5693775A (de) |
EP (2) | EP1626096A3 (de) |
JP (1) | JPH11508125A (de) |
AT (1) | ATE346083T1 (de) |
AU (1) | AU718718B2 (de) |
CA (1) | CA2220893A1 (de) |
DE (1) | DE69636720T2 (de) |
WO (1) | WO1996035708A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050019824A1 (en) * | 1994-03-08 | 2005-01-27 | Human Genome Sciences, Inc. | Fibroblast Growth Factor-10 |
US6110893A (en) * | 1995-06-05 | 2000-08-29 | Human Genome Sciences, Inc. | Fibroblast growth factor 11 |
EP0832216A4 (de) * | 1995-06-05 | 1999-06-16 | Human Genome Sciences Inc | Fibroblaster wachstumsfaktor |
US6605441B1 (en) | 1995-06-05 | 2003-08-12 | Human Genome Sciences, Inc. | Antibodies against fibroblast growth factor 11 |
US5773252A (en) * | 1995-06-05 | 1998-06-30 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
WO1996039420A1 (en) * | 1995-06-05 | 1996-12-12 | Human Genome Sciences, Inc. | Human criptin growth factor |
US6020189A (en) | 1996-08-30 | 2000-02-01 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factors (FHFs) and methods of use |
WO1998023749A1 (en) * | 1996-11-27 | 1998-06-04 | Human Genome Sciences, Inc. | Fibroblast growth factor-13 |
US6331523B1 (en) | 1998-03-12 | 2001-12-18 | Genentech, Inc. | Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 |
US7022683B1 (en) | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
US5929051A (en) * | 1998-05-13 | 1999-07-27 | Carrington Laboratories, Inc. | Aloe pectins |
US6313103B1 (en) | 1998-05-13 | 2001-11-06 | Carrington Laboratories, Inc. | Pectic substance as a growth factor stabilizer |
US20030166550A1 (en) | 1999-08-27 | 2003-09-04 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
US7018810B1 (en) * | 1999-12-07 | 2006-03-28 | Amgen Inc. | Chordin-like molecules and uses thereof |
US20060160181A1 (en) * | 2000-02-15 | 2006-07-20 | Amgen Inc. | Fibroblast Growth Factor-23 molecules and uses thereof |
US7223563B2 (en) * | 2000-07-19 | 2007-05-29 | Advanced Research And Technology Institute | Fibroblast growth factor (FGF23) nucleic acids |
US7494669B2 (en) | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
US7776825B1 (en) * | 2006-11-09 | 2010-08-17 | Florida State University Research Foundation, Incorporated | Mutant polypeptides of fibroblast growth factor 1 |
US7659379B1 (en) * | 2007-05-24 | 2010-02-09 | Florida State University Research Foundation, Inc. | Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
EP2357020B1 (de) * | 2010-02-17 | 2012-08-29 | Sorin CRM SAS | Aktive medizinische Vorrichtung vom Typ Herzschrittmacher, Defibrillator und/oder Resynchronisator mit automatischer Optimierung der atrioventrikulären Verzögerung |
CA2796459C (en) | 2010-04-16 | 2016-05-24 | Salk Institute For Biological Studies | Methods for treating metabolic disorders using fgf-1 |
WO2015061351A1 (en) * | 2013-10-21 | 2015-04-30 | Salk Institute For Biological Studies | Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use |
KR101868620B1 (ko) * | 2015-08-12 | 2018-07-23 | 중앙대학교 산학협력단 | Fgf12를 이용한 혈관 평활근세포 증식성 질환의 진단, 예방 또는 치료용 조성물 |
JP2018535964A (ja) | 2015-10-30 | 2018-12-06 | ソーク インスティテュート フォー バイオロジカル スタディーズ | 線維芽細胞増殖因子(fgf)1アナログによるステロイド誘導性高血糖の処置 |
US11542309B2 (en) | 2019-07-31 | 2023-01-03 | Salk Institute For Biological Studies | Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0703979B1 (de) * | 1993-06-04 | 2000-09-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Verfahren zur behandlung von kaposi-sarcoma mit antisense-oligonukleotide |
US5817485A (en) * | 1994-03-08 | 1998-10-06 | Human Genome Sciences, Inc. | Nucleic acids and cells for recombinant production of fibroblast growth factor-10 |
AU712297B2 (en) * | 1995-06-05 | 1999-11-04 | Human Genome Sciences, Inc. | Fibroblast growth factor 11 |
EP0832216A4 (de) * | 1995-06-05 | 1999-06-16 | Human Genome Sciences Inc | Fibroblaster wachstumsfaktor |
CA2249179A1 (en) * | 1996-03-21 | 1997-09-25 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
US6020189A (en) * | 1996-08-30 | 2000-02-01 | The Johns Hopkins University School Of Medicine | Fibroblast growth factor homologous factors (FHFs) and methods of use |
-
1995
- 1995-05-12 US US08/439,725 patent/US5693775A/en not_active Expired - Fee Related
-
1996
- 1996-05-10 DE DE69636720T patent/DE69636720T2/de not_active Expired - Fee Related
- 1996-05-10 AT AT96915685T patent/ATE346083T1/de not_active IP Right Cessation
- 1996-05-10 EP EP05019275A patent/EP1626096A3/de not_active Withdrawn
- 1996-05-10 AU AU57397/96A patent/AU718718B2/en not_active Ceased
- 1996-05-10 WO PCT/US1996/006664 patent/WO1996035708A1/en active IP Right Grant
- 1996-05-10 JP JP8534273A patent/JPH11508125A/ja active Pending
- 1996-05-10 EP EP96915685A patent/EP0825996B1/de not_active Expired - Lifetime
- 1996-05-10 CA CA002220893A patent/CA2220893A1/en not_active Abandoned
-
1997
- 1997-06-02 US US08/867,471 patent/US5872226A/en not_active Expired - Fee Related
-
1999
- 1999-02-16 US US09/251,263 patent/US20020052477A1/en not_active Abandoned
-
2003
- 2003-01-16 US US10/347,177 patent/US20030220483A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2220893A1 (en) | 1996-11-14 |
DE69636720T2 (de) | 2007-10-18 |
US5872226A (en) | 1999-02-16 |
AU5739796A (en) | 1996-11-29 |
EP1626096A3 (de) | 2007-04-11 |
EP1626096A2 (de) | 2006-02-15 |
AU718718B2 (en) | 2000-04-20 |
EP0825996A1 (de) | 1998-03-04 |
EP0825996B1 (de) | 2006-11-22 |
US20030220483A1 (en) | 2003-11-27 |
EP0825996A4 (de) | 2000-06-14 |
US5693775A (en) | 1997-12-02 |
US20020052477A1 (en) | 2002-05-02 |
ATE346083T1 (de) | 2006-12-15 |
JPH11508125A (ja) | 1999-07-21 |
WO1996035708A1 (en) | 1996-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69636720D1 (de) | Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung | |
AU735355C (en) | Novel protein and method for producing the protein | |
IS4884A (is) | Ret bindill til örvunar vaxtar tauga og thvagfæra | |
ATE430197T1 (de) | Fibroblasten wachstumsfaktor-ähnliche polypeptide | |
ATE295414T1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
NO960767D0 (no) | Protocadherinproteiner og deres anvendelse | |
DK0745124T3 (da) | Pattedyr-cellecyklusprotein | |
ATE83801T1 (de) | Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g. | |
DK564989A (da) | Bindingsproteiner | |
ATE235916T1 (de) | Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern | |
DK0572688T3 (da) | Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi | |
EE200100472A (et) | Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks | |
DE69418322D1 (de) | Analoge für spezifische oligosaccharid-protein-wechselwirkungen und ihre verwendungen | |
ATE216723T1 (de) | Hormones de croissance humaines mutantes et leur utilisation | |
EP0967283A4 (de) | Gene, die für proteine mit transglykolysierungsaktivität kodieren. | |
ATE299182T1 (de) | Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie | |
DE3854420D1 (de) | Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung. | |
EP0832109A4 (de) | Faktor-2, homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung | |
DK0941341T3 (da) | Nukleotidsekvens, der koder for en flavinmonooxygenase, det tilsvarende protein og deres anvendelser inden for diagnostik og terapi | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
DE50311090D1 (de) | Repressor der skelettmuskeldifferenzierung, dafür kodierende nucleinsäure und dessen verwendung in diagnostik und therapie | |
ATE110385T1 (de) | Derivate von aminocarboxylsäure. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |